The rs1260326 polymorphism mapped to GCKR was reportedly associated with non-alcoholic fatty liver disease and cardiovascular disease-related phenotypes [56,57]. This evidence concerns the gene GCKR and metabolic dysfunction-associated steatotic liver disease.